The oral LD50 in rats is 9690 mg/kg.L42640
There are several cases of GHB overdose in literature where individuals ingested GHB illicitly in conjunction with other drugs and alcohol. These individuals exhibited varying degrees of depressed consciousness that may fluctuate rapidly between a confusional, agitated, combative state with ataxia and coma. Emesis (even when obtunded), diaphoresis, headache, and impaired psychomotor skills have been observed. No typical pupillary changes have been described to assist in diagnosis; pupillary reactivity to light is maintained. Blurred vision has been reported. An increasing depth of coma and acidosis have been observed at higher doses. Myoclonus and tonic-clonic seizures have been reported. Respiration may be unaffected or compromised in rate and depth. Cheyne-Stokes respiration and apnea have been observed. Bradycardia and hypothermia may accompany unconsciousness, as well as muscular hypotonia, but tendon reflexes remain intact.L30598
In clinical trials, two adults experienced sodium oxybate overdose. One patient received an estimated dose of 150 g, which was more than 15 times the maximum recommended dose: this patient became unresponsive with brief periods of apnea and incontinent of urine and feces. The patient recovered without sequelae. The other patient died following a multiple drug overdose consisting of sodium oxybate and numerous other drugs.L30598
There is no known antidote for sodium oxybate; therefore, overdose should be managed with general symptomatic and supportive care, with a consideration of gastric decontamination if co-ingestants are suspected.L30598
Sodium oxybate (Xyrem) is a central nervous system (CNS) depressant used to treat cataplexy or excessive daytime sleepiness associated with narcolepsy.L30598 It is a sodium salt of gamma-Hydroxybutyric acid, an endogenous cerebral inhibitory neurotransmitter A251445 and a metabolite of the inhibitory neurotransmitter GABA.A251430 Due to its physiological effects, sodium oxybate is associated with a risk for substance misuse and abuse. Sodium oxybate has been misused to stimulate body growth and to induce euphoria, disinhibition, and sexual arousal as a "party drug" or "club drug."A18723 For safety reasons, sodium oxybate is a controlled substance only available through a restricted program in approved countries.L30598
An extended-release oral suspension formulation of sodium oxybate for narcolepsy, marketed under the brand name LUMRYZ, gained tentative FDA approval in July 2022 L42645 and was fully approved in May 2023.L46302 In some countries, sodium oxybate has been investigated and used in alcohol withdrawal syndrome (AWS) to aid abstinence maintenance in alcohol use disorders.A251440, A251445
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Hydrocodone | Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Magnesium sulfate | Magnesium sulfate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Methotrimeprazine | Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Metyrosine | Sodium oxybate may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Mirtazapine | Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Orphenadrine | Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Pramipexole | Sodium oxybate may increase the sedative activities of Pramipexole. |
| Ropinirole | Sodium oxybate may increase the sedative activities of Ropinirole. |
| Rotigotine | Sodium oxybate may increase the sedative activities of Rotigotine. |
| Rufinamide | Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Sodium oxybate. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Sodium oxybate. |
| Tryptophan | Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Fluvoxamine | Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Sodium oxybate. |
| Reserpine | Reserpine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Citalopram | Citalopram may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Eletriptan | Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Enflurane | Enflurane may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Reboxetine | Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Methysergide | Methysergide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Cabergoline | Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Phenytoin | Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Topiramate | Topiramate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Clemastine | Clemastine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Venlafaxine | Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Morphine | Morphine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Zolmitriptan | Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Codeine | Codeine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dihydroergotamine | Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Amitriptyline | Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Tolcapone | Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Hydromorphone | Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Cetirizine | Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Protriptyline | Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Trimethadione | Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Chlorzoxazone | Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Clozapine | Clozapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Thiethylperazine | Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Palonosetron | Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Sulpiride | Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dexbrompheniramine | Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Loxapine | Loxapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Remoxipride | Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Sodium oxybate. |
| Promazine | Promazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Methocarbamol | Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Triprolidine | Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Prochlorperazine | Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Cyproheptadine | Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Meperidine | Meperidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Imipramine | Imipramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Metharbital | Metharbital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Quinine | Quinine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Duloxetine | Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Chlorpromazine | Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Gallamine triethiodide | The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Sodium oxybate. |
| Entacapone | Entacapone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Oxycodone | Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Triflupromazine | Triflupromazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dextromethorphan | Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Mephenytoin | Mephenytoin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Nortriptyline | Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Amoxapine | Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Lamotrigine | Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Carbamazepine | Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Cisatracurium | The risk or severity of CNS depression can be increased when Cisatracurium is combined with Sodium oxybate. |
| Fenfluramine | Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Mazindol | Mazindol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Fluticasone propionate | Fluticasone propionate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Lisuride | Lisuride may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Ethosuximide | Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Cisapride | Cisapride may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Butorphanol | The risk or severity of CNS depression can be increased when Butorphanol is combined with Sodium oxybate. |
| Furazolidone | Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Paramethadione | Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Fluphenazine | Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Efavirenz | Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dyclonine | Dyclonine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Dextropropoxyphene | Dextropropoxyphene may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Pentazocine | Pentazocine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Trazodone | Trazodone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Metaxalone | Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Trimethobenzamide | Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Sumatriptan | Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Thioridazine | Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Moricizine | Moricizine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Ergotamine | Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Tizanidine | Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Sufentanil | Sufentanil may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Apomorphine | The risk or severity of CNS depression can be increased when Apomorphine is combined with Sodium oxybate. |